AZ-67

N/A

Report date: 2025/01/26 18:14:14
NME

Base Information

Drug NameAZ-67
Drug Alias NamePFKFB3 inhibitor (Gero)PFKFB3 inhibitors (Gero/Quantum Pharmaceuticals)AZ-67
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 inhibitors
Targets6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
Therapy Area/IndicationsSolid tumoursNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGero Discovery
China Registration ClassN/A

Develop Information

Active CompaniesQuantum Pharmaceuticals LLCGero Discovery
Inactive CompaniesN/A
Active IndicationsSolid tumoursNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A